Online vape store Veppo has announced a blowout Black Friday sale. Online PR News � 28-November-2019 One could say its been a rough couple of months for vapers in the United States, but theyve definitely got reason to smile now. Veppo has just announced their Black Friday sale starting this Thanksgiving day all the way through Cyber Monday! With the holiday season coming up, you may want to invest in that vaporizer youve been eyeing for a while, or help a smoker in your life make the switch to e-cigarettes. Regardless of what youre looking for, youll most definitely find something that matches your needs and your budget. Veppos range of product offerings includes e-cigarettes, vape mods, vaporizers, e-cigars, e-liquid, cartomizers, and accessories. The massive collection includes Veppos own much-loved designs, as well as popular brands like Kanger, Eleaf and The Vault, to name a few. The Black Friday sale will have dynamic deals on different items. In fact, this is as good a time as any to sign up for the Veppo newsletter so you dont miss out on insider deals or sale extensions. Despite the fact that vape-related issues seem to correlate with black market THC vape products with crude thickening agents, the response from anti-vape lobbyists has been alarmist. The future of legitimate, legal vapes is also in jeopardy. This Black Friday, stock up for the possible vape-pocalypse at http://veppocig.com/ |
Sabina King |
http://veppocig.com/ |
303-872-8188 |
RIYADH, SAUDI ARABIA - Media OutReach Newswire - 29 April 2024 - Sahm, the all-in-one…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - From 26 April to 12…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…